Vancouver Researcher-Physicians Win Top $100,000 EnCana Principal Award
A combination stent-drug delivery vehicle developed by two Vancouver MDs is saving the lives of cardiovascular disease patients worldwide.  In recognition of their contribution, William Hunter, MD, and Lindsay Machan, MD, of Angiotech Pharmaceuticals, Inc. have won this year's $100,000 EnCana Principal Award, sponsored by EnCana Corporation—the top prize from the Ernest C. Manning Awards Foundation.

BC Advantage Funds Awarded Venture Capital "Deal of the Year
BC Advantage Funds VCC, a Vancouver-based life science and technology venture capital fund, received the 2006 Deal of the Year Award from the Canadian Venture Capital Association for its return on investment in Aspreva Pharmaceuticals